431 related articles for article (PubMed ID: 11551102)
1. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
[TBL] [Abstract][Full Text] [Related]
2. Common origin of the I1307K APC polymorphism in Ashkenazi and non-Ashkenazi Jews.
Patael Y; Figer A; Gershoni-Baruch R; Papa MZ; Risel S; Shtoyerman-Chen R; Karasik A; Theodor L; Friedman E
Eur J Hum Genet; 1999 Jul; 7(5):555-9. PubMed ID: 10439961
[TBL] [Abstract][Full Text] [Related]
3. Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype.
Drucker L; Shpilberg O; Neumann A; Shapira J; Stackievicz R; Beyth Y; Yarkoni S
Cancer; 2000 Feb; 88(4):755-60. PubMed ID: 10679643
[TBL] [Abstract][Full Text] [Related]
4. The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews.
Boursi B; Sella T; Liberman E; Shapira S; David M; Kazanov D; Arber N; Kraus S
Eur J Cancer; 2013 Nov; 49(17):3680-5. PubMed ID: 23896379
[TBL] [Abstract][Full Text] [Related]
5. Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: evidence of genetic drift within the Ashkenazim.
Niell BL; Long JC; Rennert G; Gruber SB
Am J Hum Genet; 2003 Dec; 73(6):1250-60. PubMed ID: 14624392
[TBL] [Abstract][Full Text] [Related]
6. Genetic analyses in consecutive israeli jewish colorectal cancer patients.
Fidder HH; Figer A; Geva R; Flex D; Schayek H; Avidan B; Meir SB; Friedman E
Am J Gastroenterol; 2005 Jun; 100(6):1376-80. PubMed ID: 15929773
[TBL] [Abstract][Full Text] [Related]
7. Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia. Evidence for a founder effect.
Rozen P; Naiman T; Strul H; Taussky P; Karminsky N; Shomrat R; Samuel Z; Yaron Y; Orr-Urtreger A
Cancer; 2002 May; 94(10):2561-8. PubMed ID: 12173321
[TBL] [Abstract][Full Text] [Related]
8. The I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews.
Strul H; Barenboim E; Leshno M; Gartner M; Kariv R; Aljadeff E; Aljadeff Y; Kazanov D; Strier L; Keidar A; Knaani Y; Degani Y; Alon-Baron L; Sobol-Dvory H; Halpern Z; Arber N
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1012-5. PubMed ID: 14578136
[TBL] [Abstract][Full Text] [Related]
9. The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds.
Petrukhin L; Dangel J; Vanderveer L; Costalas J; Bellacosa A; Grana G; Daly M; Godwin AK
Cancer Res; 1997 Dec; 57(24):5480-4. PubMed ID: 9407954
[TBL] [Abstract][Full Text] [Related]
10. The I1307K polymorphism of the APC gene in colorectal cancer.
Prior TW; Chadwick RB; Papp AC; Arcot AN; Isa AM; Pearl DK; Stemmermann G; Percesepe A; Loukola A; Aaltonen LA; De La Chapelle A
Gastroenterology; 1999 Jan; 116(1):58-63. PubMed ID: 9869603
[TBL] [Abstract][Full Text] [Related]
11. Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin.
Silverberg MS; Clelland C; Murphy JE; Steinhart AH; McLeod RS; Greenberg GR; Cohen Z; Siminovitch KA
Hum Genet; 2001 Mar; 108(3):205-10. PubMed ID: 11354631
[TBL] [Abstract][Full Text] [Related]
12. Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms.
Zauber NP; Sabbath-Solitare M; Marotta S; Zauber AG; Foulkes W; Chan M; Turner F; Bishop DT
Cancer; 2005 Aug; 104(4):719-29. PubMed ID: 15959913
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps.
Syngal S; Schrag D; Falchuk M; Tung N; Farraye FA; Chung D; Wright M; Whetsell A; Miller G; Garber JE
JAMA; 2000 Aug; 284(7):857-60. PubMed ID: 10938175
[TBL] [Abstract][Full Text] [Related]
14. The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features.
Locker GY; Kaul K; Weinberg DS; Gatalica Z; Gong G; Peterman A; Lynch J; Klatzco L; Olopade OI; Bomzer CA; Newlin A; Keenan E; Tajuddin M; Knezetic J; Coronel S; Lynch HT
Cancer Genet Cytogenet; 2006 Aug; 169(1):33-8. PubMed ID: 16875934
[TBL] [Abstract][Full Text] [Related]
15. APC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews.
Stern HS; Viertelhausen S; Hunter AG; O'Rourke K; Cappelli M; Perras H; Serfas K; Blumenthall A; Dewar D; Baumann E; Lagarde AE
Gastroenterology; 2001 Feb; 120(2):392-400. PubMed ID: 11159880
[TBL] [Abstract][Full Text] [Related]
16. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA
Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801
[TBL] [Abstract][Full Text] [Related]
17. Somatic instability of the APC I1307K allele in colorectal neoplasia.
Gryfe R; Di Nicola N; Gallinger S; Redston M
Cancer Res; 1998 Sep; 58(18):4040-3. PubMed ID: 9751605
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer.
Rozen P; Shomrat R; Strul H; Naiman T; Karminsky N; Legum C; Orr-Urtreger A
Gastroenterology; 1999 Jan; 116(1):54-7. PubMed ID: 9869602
[TBL] [Abstract][Full Text] [Related]
19. Low prevalence of the APC I1307K sequence in Jewish and non-Jewish patients with inflammatory bowel disease.
Yin J; Harpaz N; Souza RF; Zou T; Kong D; Wang S; Leytin AL; Medalie NS; Smolinski KN; Abraham JM; Fleisher AS; Meltzer SJ
Oncogene; 1999 Jul; 18(26):3902-4. PubMed ID: 10445854
[TBL] [Abstract][Full Text] [Related]
20. Position statement of the International Society for Gastrointestinal Hereditary Tumours (InSiGHT) on
Valle L; Katz LH; Latchford A; Mur P; Moreno V; Frayling IM; Heald B; Capellá G;
J Med Genet; 2023 Nov; 60(11):1035-1043. PubMed ID: 37076288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
